Movano (MOVE) said Tuesday it has begun a clinical trial with its new cuffless blood pressure wrist wearable.
The company said in the study, the device will be used to monitor pulse pressure waveforms compared with a hospital grade blood pressure device and will also collect data on pulse rate, blood oxygen saturation and other vital signs.
The trial is expected to include at least 70 participants and be finished in the second week of February, Movano said.
The company said the study follows three clinical trials where it used its non-invasive devices to collect pulse pressure waveform data from more than 60 participants.
Price: 5.43, Change: +0.03, Percent Change: +0.56
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。